Exploring the effects of extracranial injections of botulinum toxin type A on activation and sensitization of central trigeminovascular neurons by cortical spreading depression in male and female rats

The ability of onabotA to prevent activation and sensitization of WDR neurons is attributed to its preferential inhibitory effects on unmyelinated C-fibers. The inability of onabotA to prevent activation of HT neurons is attributed to its less extensive inhibitory effects on the thinly myelinated Aδ-fibers. These findings provide further pre-clinical evidence about differences and potentially complementary mechanisms of action of onabotA and calcitonin gene-related peptide-signaling neutralizing drugs.

Authors

Institutions

Publication Details

Journal
Cephalalgia
Published
2024-09-01
DOI
https://doi.org/10.1177/03331024241278919
Citations
6
Primary Topic
Migraine and Headache Studies
Type
article
Field-Weighted Citation Impact
2.31

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exploring the effects of extracranial injections of botulinum toxin type A on activation and sensitization of central trigeminovascular neurons by cortical spreading depression in male and female rats

Rami Burstein, Brett Dabruzzo, Andrew M. Strassman, Agustin Melo‐Carrillo et al.
6 citations
Cephalalgia
Migraine and Headache Studies
2.31
article

Exploring the effects of extracranial injections of botulinum toxin type A on activation and sensitization of central trigeminovascular neurons by cortical spreading depression in male and female rats

Rami Burstein, Brett Dabruzzo, Andrew M. Strassman, Agustin Melo‐Carrillo, Mitchell F. Brin, Aubrey Manack Adams, Khrystoffer-Kihan J. Malcolm, Ron S. Briode
article en
6 citations

Abstract

The ability of onabotA to prevent activation and sensitization of WDR neurons is attributed to its preferential inhibitory effects on unmyelinated C-fibers. The inability of onabotA to prevent activation of HT neurons is attributed to its less extensive inhibitory effects on the thinly myelinated Aδ-fibers. These findings provide further pre-clinical evidence about differences and potentially complementary mechanisms of action of onabotA and calcitonin gene-related peptide-signaling neutralizing drugs.

CephalalgiaVol. 44(9)
Beth Israel Deaconess Medical Center (US), Harvard University (US), University of California, Irvine (US), AbbVie (United States) (US), Allergan (United States) (US)
AbbVie, National Institute of Neurological Disorders and Stroke
Good health and well-being
Openalex Percentile: Top 11%
Migraine and Headache Studies
2.31
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.